View source for 1avv

==HIV-1 NEF PROTEIN, UNLIGANDED CORE DOMAIN==
<StructureSection load='1avv' size='340' side='right' caption='[[1avv]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[1avv]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/9hiv1 9hiv1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1AVV OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1AVV FirstGlance]. <br>
</td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">HIV-1 NEF ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=11676 9HIV1])</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1avv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1avv OCA], [http://pdbe.org/1avv PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=1avv RCSB], [http://www.ebi.ac.uk/pdbsum/1avv PDBsum]</span></td></tr>
</table>
== Function ==
[[http://www.uniprot.org/uniprot/NEF_HV1BR NEF_HV1BR]] Factor of infectivity and pathogenicity, required for optimal virus replication. Alters numerous pathways of T-lymphocytes function and down-regulates immunity surface molecules in order to evade host defense and increase viral infectivity. Alters the functionality of other immunity cells, like dendritic cells, monocytes/macrophages and NK cells. One of the earliest and most abundantly expressed viral proteins (By similarity).<ref>PMID:8151761</ref> <ref>PMID:8124721</ref> <ref>PMID:10684310</ref> <ref>PMID:11070003</ref> <ref>PMID:11285224</ref> <ref>PMID:11298454</ref> <ref>PMID:11861836</ref> <ref>PMID:14617802</ref> <ref>PMID:15854903</ref> <ref>PMID:16928758</ref> <ref>PMID:18005690</ref>   In infected CD4(+) T-lymphocytes, down-regulates the surface MHC-I, mature MHC-II, CD4, CD28, CCR5 and CXCR4 molecules. Mediates internalization and degradation of host CD4 through the interaction of with the cytoplasmic tail of CD4, the recruitment of AP-2 (clathrin adapter protein complex 2), internalization through clathrin coated pits, and subsequent transport to endosomes and lysosomes for degradation. Diverts host MHC-I molecules to the trans-Golgi network-associated endosomal compartments by an endocytic pathway to finally target them for degradation. MHC-I down-regulation may involve AP-1 (clathrin adapter protein complex 1) or possibly Src family kinase-ZAP70/Syk-PI3K cascade recruited by PACS2. In consequence infected cells are masked for immune recognition by cytotoxic T-lymphocytes. Decreasing the number of immune receptors also prevents reinfection by more HIV particles (superinfection).<ref>PMID:8151761</ref> <ref>PMID:8124721</ref> <ref>PMID:10684310</ref> <ref>PMID:11070003</ref> <ref>PMID:11285224</ref> <ref>PMID:11298454</ref> <ref>PMID:11861836</ref> <ref>PMID:14617802</ref> <ref>PMID:15854903</ref> <ref>PMID:16928758</ref> <ref>PMID:18005690</ref>   Bypasses host T-cell signaling by inducing a transcriptional program nearly identical to that of anti-CD3 cell activation. Interaction with TCR-zeta chain up-regulates the Fas ligand (FasL). Increasing surface FasL molecules and decreasing surface MHC-I molecules on infected CD4(+) cells send attacking cytotoxic CD8+ T-lymphocytes into apoptosis (By similarity).<ref>PMID:8151761</ref> <ref>PMID:8124721</ref> <ref>PMID:10684310</ref> <ref>PMID:11070003</ref> <ref>PMID:11285224</ref> <ref>PMID:11298454</ref> <ref>PMID:11861836</ref> <ref>PMID:14617802</ref> <ref>PMID:15854903</ref> <ref>PMID:16928758</ref> <ref>PMID:18005690</ref>   Plays a role in optimizing the host cell environment for viral replication without causing cell death by apoptosis. Protects the infected cells from apoptosis in order to keep them alive until the next virus generation is ready to strike. Inhibits the Fas and TNFR-mediated death signals by blocking MAP3K5. Interacts and decreases the half-life of p53, protecting the infected cell against p53-mediated apoptosis. Inhibits the apoptotic signals regulated by the Bcl-2 family proteins through the formation of a Nef/PI3-kinase/PAK2 complex that leads to activation of PAK2 and induces phosphorylation of Bad (By similarity).<ref>PMID:8151761</ref> <ref>PMID:8124721</ref> <ref>PMID:10684310</ref> <ref>PMID:11070003</ref> <ref>PMID:11285224</ref> <ref>PMID:11298454</ref> <ref>PMID:11861836</ref> <ref>PMID:14617802</ref> <ref>PMID:15854903</ref> <ref>PMID:16928758</ref> <ref>PMID:18005690</ref>   Extracellular Nef protein targets CD4(+) T-lymphocytes for apoptosis by interacting with CXCR4 surface receptors (By similarity).<ref>PMID:8151761</ref> <ref>PMID:8124721</ref> <ref>PMID:10684310</ref> <ref>PMID:11070003</ref> <ref>PMID:11285224</ref> <ref>PMID:11298454</ref> <ref>PMID:11861836</ref> <ref>PMID:14617802</ref> <ref>PMID:15854903</ref> <ref>PMID:16928758</ref> <ref>PMID:18005690</ref>  
== Evolutionary Conservation ==
[[Image:Consurf_key_small.gif|200px|right]]
Check<jmol>
  <jmolCheckbox>
    <scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/av/1avv_consurf.spt"</scriptWhenChecked>
    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
    <text>to colour the structure by Evolutionary Conservation</text>
  </jmolCheckbox>
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/chain_selection.php?pdb_ID=2ata ConSurf].
<div style="clear:both"></div>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
BACKGROUND: Human immunodeficiency virus (HIV) Nef protein accelerates virulent progression of acquired immunodeficiency syndrome (AIDS) by its interaction with specific cellular proteins involved in signal transduction and host cell activation. Nef has been shown to bind specifically to a subset of the Src family of kinases. The structures of free Nef and Nef bound to Src homology region 3 (SH3) domain are important for the elucidation of how the affinity and specificity for the Src kinase family SH3 domains are achieved, and also for the development of potential drugs and vaccines against AIDS. RESULTS: We have determined the crystal structures of the conserved core of HIV-1 Nef protein alone and in complex with the wild-type SH3 domain of the p59fyn protein tyrosine kinase (Fyn), at 3.0 A resolution. Comparison of the bound and unbound Nef structures revealed that a proline-rich motif (Pro-x-x-Pro), which is implicated in SH3 binding, is partially disordered in the absence of the binding partner; this motif only fully adopts a left-handed polyproline type II helix conformation upon complex formation with the Fyn SH3 domain. In addition, the structures show how an arginine residue (Arg77) of Nef interacts with Asp 100 of the so-called RT loop within the Fyn SH3 domain, and triggers a hydrogen-bond rearrangement which allows the loop to adapt to complement the Nef surface. The Arg96 residue of the Fyn SH3 domain is specifically accommodated in the same hydrophobic pocket of Nef as the isoleucine residue of a previously described Fyn SH3 (Arg96--&gt;lle) mutant that binds to Nef with higher affinity than the wild type. CONCLUSIONS: The three-dimensional structures support evidence that the Nef-Fyn complex forms in vivo and may have a crucial role in the T cell perturbating action of Nef by altering T cell receptor signaling. The structures of bound and unbound Nef reveal that the multivalency of SH3 binding may be achieved by a ligand induced flexibility in the RT loop. The structures suggest possible targets for the design of inhibitors which specifically block Nef-SH3 interactions.

The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling.,Arold S, Franken P, Strub MP, Hoh F, Benichou S, Benarous R, Dumas C Structure. 1997 Oct 15;5(10):1361-72. PMID:9351809<ref>PMID:9351809</ref>

From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 1avv" style="background-color:#fffaf0;"></div>
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Arold, S]]
[[Category: Dumas, C]]
[[Category: Franken, P]]
[[Category: Gtp-binding]]
[[Category: Hiv-1]]
[[Category: Myristylation]]
[[Category: Nef]]
[[Category: Phosphorylation]]
[[Category: Pxxp motif]]
[[Category: Virus]]